# Charging for Investigational Drugs Under an IND: Questions and Answers - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/charging-for-investigational-drugs-under-an-ind-questions-and-answers/e6ac16bc-3e90-4996-b2e5-b9671d33c720

> FDA guidance document: Charging for Investigational Drugs Under an IND: Questions and Answers. Issue date: February 14, 2024. Get complete insights and analysis.

---

## Details

- Title: Charging for Investigational Drugs Under an IND: Questions and Answers
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2024-02-14
- Last Changed: 2024-02-16
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2013-D-0447">FDA-2013-D-0447</a>

## Related Documents

- [Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/expanded-access-to-investigational-drugs-for-treatment-use-questions-and-answers/9bb69e41-e105-4381-9ff7-898811ff1b7c)
- [Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products](https://www.globalkeysolutions.net/guidances/guidance-document/adjusting-for-covariates-in-randomized-clinical-trials-for-drugs-and-biological-products/f58b2adc-b92a-4458-b269-5346d25a8a39)
- [Reporting Amount of Listed Drugs and Biological Products Technical Conformance Guide:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/reporting-amount-of-listed-drugs-and-biological-products-technical-conformance-guide-guidance-for-industry/4222c78a-5db6-449e-826e-6bfd5b426574)